CUPERTINO, CA, April 12, 2018 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ: AMTX) today announced that
Universal Biofuels, the company’s India subsidiary, is producing glycerin at above nameplate capacity and demand for the product
exceeds supply. The production capacity of the refined glycerin unit at the Kakinada plant is approximately 18,000 metric tonnes
per year. The sale of glycerin is an important part of the company’s business strategy in India.
“Our glycerin refining facility in India is operating above nameplate capacity by importing crude glycerin from
Argentina and other biodiesel production countries,” stated Eric McAfee, Chairman and CEO of Aemetis. “As our plant scales up
biodiesel production using the new pre-treatment unit, the refined glycerin production unit has grown to be an important source of
consistent revenues and contribution margins supplying the production of consumer and paint products in India.”
About Aemetis
Headquartered in Cupertino, California, Aemetis is an advanced renewable fuels and biochemicals company focused on
the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products by
the conversion of ethanol and biodiesel plants into advanced biorefineries. Founded in 2006, Aemetis owns and operates a 60
million gallon per year ethanol production facility in California’s Central Valley, near Modesto. Aemetis also owns and
operates a 50 million gallon per year renewable chemical and advanced fuel production facility on the East Coast of India producing
high quality distilled biodiesel and refined glycerin for customers in India, the US and Europe. Aemetis operates a research
and development laboratory, and holds a portfolio of patents and related technology licenses for the production of renewable fuels
and biochemicals. For additional information about Aemetis, please visit www.aemetis.com.
External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 ksmith@pcgadvisory.com Company Investor Relations/ Media Contact: Todd Waltz (408) 213-0940 investors@aemetis.com
